
Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS‐CoV‐2 at 6 Months Following Vaccination in Healthy Individuals
Author(s) -
NtanasisStathopoulos Ioannis,
Karalis Vangelis,
Sklirou Aimilia D.,
Gavriatopoulou Maria,
Alexopoulos Harry,
Malandrakis Panagiotis,
Trougakos Ioannis P.,
Dimopoulos Meletios A.,
Terpos Evangelos
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000747
Subject(s) - covid-19 , virology , vaccination , medicine , antibody , neutralizing antibody , immunology , infectious disease (medical specialty) , outbreak , disease